Scientists at the University of Massachusetts Amherst have developed a ‘super vaccine’ that totally prevents the deadly disease from forming in laboratory mice. The experimental vaccine, powered by a special immune-boosting formula, has helped the immune systems of animals to recognise and destroy cancer cells before they could grow into tumours.
In many tests and trials that were conducted mostly on mice, most of the vaccinated ones remained healthy, while the unvaccinated developed cancer. According to scientists who participated in the experiment, this game-changing innovation could open the door to a future where cancer gets stopped even before it starts.
According to the scientists, the vaccine works as it trains the body’s natural defences to spot and attack abnormal cells that may turn into cancer. Instead of targeting just one type of cancer, it appears to offer protection against several aggressive kinds, which include melanoma, pancreatic cancer, and breast cancer. The early tests that were done on animals most of the vaccinated mice showed no signs of tumours, which suggested the body can fight against cancer before it takes hold and spreads all over.
However, the vaccine not only prevents new tumours but also stops the disease from mutating and spreading to other parts of the body. Experts say it can be a win-win situation, especially in cancers that lead to a high number of deaths due to metastasis, when the disease travels to vital organs like the lungs, brain, or liver. If the same protection can be achieved in humans, it could mark a huge step towards saving millions of lives.
Scientists say the vaccine works against cancer as it forms from the body’s own cells along with a unique ingredient, known as a super adjuvant. It is said to boost the immune response much more strongly than normal vaccine formulas, thereby letting the immune cells find and destroy cancer cells faster and more effectively.
However, it is being cautioned that even though results have been impressive in animal studies, research is still in its early stages, and human trials are yet to be done. Scientists say it may take decades of additional testing before it can be safely used in humans to wipe out cancer, if at all.
